|
15190 Federal Register/Vol. 81, No. 55/Tuesday, March 22, 2016/Proposed Rules
<br />and Human Services (HHS),' or (3) on
<br />the petition of any interested party. 21
<br />U.S.C. 811(a). This proposed action (80
<br />FR 27611, May 14, 2015) is supported
<br />by a recommendation from the Assistant
<br />Secretary of the HHS and an evaluation
<br />of all other relevant data by the DEA. If
<br />finalized, this action would impose the
<br />regulatory controls and administrative,
<br />civil, and criminal sanctions of schedule
<br />I controlled substances on any person
<br />who handles, or proposes to handle,
<br />UR -144, XLRI1, or AKB48.
<br />Background
<br />UR -144, XLRll, and AKB48 are
<br />currently subject to schedule I controls
<br />on a temporary basis, pursuant to 21
<br />U.S.C. 811(h). 80 FR 27854, May 15,
<br />2015. On May 14, 2015, the
<br />Administrator of the DEA published a
<br />notice of proposed rulemaking (NPRM)
<br />to permanently schedule (1-pentyl-lH-
<br />indol-3-yl)(2,2,3,3-
<br />tetramethylcyclopropyl)methanone (UR -
<br />144), (1-(5-fluoro-pentyl)-1H-indol-3-
<br />yl)(2,2,3,3-
<br />tetramethylcyclopropyl)methanone (5 -
<br />fluoro -UR -144, XLRII), and N-0-
<br />adamantyl)-1-pentyl-iH-indazole-3-
<br />carboxamide (APINACA, AKB48) into
<br />schedule I pursuant to the CSA. 80 FR
<br />27611.
<br />In the NPRM, the DEA inadvertently
<br />proposed the addition of these
<br />substances in schedule I under 21 CFR
<br />1308.11(g), cannabimimetic agents, by
<br />adding paragraphs (g)(16) through (18).
<br />These substances should have been
<br />proposed to be added in schedule I
<br />under 21 CFR 1308.11(d),
<br />hallucinogenic substances. This
<br />rulemaking therefore corrects the NPRM
<br />by proposing the placement of these
<br />substances in 21 CFR 1308.11(d) by
<br />adding paragraphs (d)(48) through (50).
<br />Because the DEA is proposing to classify
<br />these substances as schedule I
<br />hallucinogenic substances, then by
<br />operation of 21 U.S.C. 802(14), this
<br />classification will include any optical,
<br />positional, or geometric isomers.
<br />Interested persons may file written
<br />comments on this change in accordance
<br />with 21 CFR 1308.43(8). The DEA is
<br />requesting comments on this change
<br />only and is not soliciting comments on
<br />other aspects of the May 14, 2015,
<br />NPRM. The DEA previously had
<br />provided an opportunity for comments
<br />on other aspects of the NPRM on May
<br />14, 2015, through June 15, 2015.
<br />Regulatory Analyses
<br />This correction has no effect on the
<br />regulatory analyses statements that were
<br />published with the notice of proposed
<br />rulemaking published in the Federal
<br />Register on May 14, 2015, at 80 FR
<br />27611.
<br />Correction
<br />In proposed rule FR Doc. 2015-11762,
<br />beginning on page 27611 in the issue of
<br />May 14, 2015, make the following
<br />corrections.
<br />■ 1. On page 27616 in the 3rd column,
<br />correct amendatory instruction 2.a. to
<br />read as follows: "Adding paragraphs
<br />(d)(65) through (67); and".
<br />■ 2. On page 27616 in the 3rd column,
<br />correct § 1308.11 Schedule I regulatory
<br />text to read as follows:
<br />§1308.11 Schedule 1.
<br />(d) • k f
<br />(65) (1-pentyl-lH-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)................................................................... (7144)
<br />(66) (1-(5-fluoro-pentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (5 -fluoro -UR -144, XLR1i) ........................ (7011)
<br />(67) N41-adamantyl)-1-pentyl-lH-indazole-3-carboxamide (APINACA, AKB48) ...................................................................... (7048)
<br />Dated: March 16, 2016.
<br />Chuck Rosenberg,
<br />Acting Administrator.
<br />(FR Doc. 2016-06474 Filed 3-21-16; 8:45 aml
<br />1311 -LING CODE 4410-0Y
<br />DEPARTMENT OF THE INTERIOR
<br />Bureau of Ocean Energy Management
<br />30 CFR Part 583
<br />RIN 1010—AD90
<br />[Docket 10: BOEM-2010-00411
<br />Negotiated Noncompetitive Leasing for
<br />the Use of Sand, Gravel, and Shell
<br />Resources on the Outer Continental
<br />Shelf
<br />AGENCY: Bureau of Ocean Energy
<br />Management, Interior.
<br />ACTIDN: Proposed rule.
<br />SUMMARY: This rule proposes regulations
<br />to address the use of Outer Continental
<br />Shelf (OCS) sand, gravel and shell
<br />resources for. shore protection, beach
<br />restoration, or coastal wetlands
<br />restoration projects by Federal, State, or
<br />local government agencies, or use in
<br />construction projects authorized by or
<br />funded in whole or in part by the
<br />Federal Government. The proposed rule
<br />describes the negotiated noncompetitive
<br />agreement process for qualifying
<br />projects and codifies new and existing
<br />procedures.
<br />DATES: Submit comments by May 23,
<br />2016. The Bureau of Ocean Energy
<br />Management (BOEM) may not fully
<br />consider comments received after this
<br />date. Submit comments to the Office of
<br />Management and Budget (OMB) on the
<br />information collection (IC) burden in
<br />this proposed rule by April 21, 2016.
<br />This does not affect the deadline for the
<br />public to comment to BOEM on the
<br />proposed regulation.
<br />ADDRESSES: You may submit comments
<br />on the rulemaking by any of the
<br />following methods. Please use the
<br />Regulation Identifier Number (RIN)
<br />1010—AD90.as an identifier in your
<br />comment. Please reference "Outer
<br />Continental Shelf Marine Sand, Gravel
<br />and Shell Resources, 1010—AD90" in
<br />your comments and include your name
<br />and return address.
<br />• Federal eRulemaking Portal: http://
<br />www.regulations.gov. Under the tab
<br />"More Search Options," click
<br />"Advanced Docket Search," then select
<br />"Bureau of Ocean Energy Management"
<br />from the agency drop-down menu, then
<br />click the submit button. In the Docket ID
<br />column, select BOEM-2010-0041 to
<br />submit public comments and to view
<br />supporting and related materials
<br />available for this rulemaking.
<br />Information on using Regulations.gov,
<br />including instructions for accessing
<br />documents, submitting comments, and
<br />viewing the docket after the close of the
<br />comment period, is available.through
<br />the site's "User Tips" link..BOEM will
<br />post comments on www.regulatiozis.gov.
<br />• Mail or hand -carry comments to the
<br />U.S. Department of the Interior; Bureau
<br />of Ocean Energy Management; Attn:
<br />Office of Policy, Regulation and
<br />Analysis, 45600 Woodland Road, VAM—
<br />BOEM DIR, Sterling, Virginia 20166.
<br />• Send comments on the IC in this
<br />proposed rule to: Interior Desk.Officar
<br />1010—AD90, Office of Management and
<br />Budget; 202-395-5806 (fax); email:
<br />3 As discussed in a memorandum of within the HHS in carrying out the Secretary's Assistant Secretary for Health of the HHS the
<br />understanding entered into by the Food and Drug scheduling responsibilities under the CSA, with the authority to make domestic drug scheduling
<br />Administration (FDA) and the National Institute on concurrence of NIDA. 50 FR 9518, Mar. 8, 1985. recommendations. 56 FR 35460, July 1, 1993.
<br />Drug Abuse (NIDA), the FDA acts as the lead agency The Secretary of the HHS has delegated to the
<br />117
<br />
|